Advertisement

Topics

Denovo Biolabels GmbH Company Profile

09:09 EST 17th December 2018 | BioPortfolio

Denovo Biolabels GmbHspecializes in the development of fluorescent markers for bioanalytical application

Location

Mendelstr.7
Monster
D-48149
Germany

Contact

Phone: 48 251 980 2918
Fax: 49 251 980 2917
Email: info@biolabels.com


News Articles [162 Associated News Articles listed on BioPortfolio]

Denovo Licenses Previously Unknown Use of Cancer Drug for PAH

Denovo, a San Diego-Beijing precision medicine company, announced an unusual global license with the Stanford University School of Medicine to develop Denovo's own lead oncology drug for pulmonary art...

Denovo gets IP from Stanford

Denovo Biopharma LLC received exclusive global rights to intellectual property from Stanford University School of Medicine that the company will use to develop lead compound, enzastaurin (DB102) as a ...

Denovo Biomarkers: Robert Little. Providing a novel biomarker solution to personalize drug development

Robert Little, the Chief Business Officer of Denovo Biomarkers reveals to Fintan Walton the use of its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospect...

Denovo gains IP from Stanford to develop lead program for new indication

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Laufende Fusionskontrollverfahren: Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);

Datum der Anmeldung:28.08.2018Aktenzeichen:B3-128/18Unternehmen:Bruker Daltonik GmbH, Bremen (D); Erwerb einer Mehrheitsbeteiligung von 80% an der HAIN LIFESCIENCE GmbH, Nehren (D);Produktmärkte:in.....

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In....

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

A comparison of different farrowing systems - Part 1: Effects on the activity of the sow.

The aim of this study was to determine whether a 3-axis accelerometer (MSR 145B V5.106, MSR Electronics GmbH, Seuzach, Switzerland) can continuously record and display the activity behaviour of sows o...

Alterations in the gut bacterial microbiome in fungal Keratitis patients.

Dysbiosis in the gut microbiome has been implicated in several diseases including auto-immune diseases, inflammatory diseases, cancers and mental disorders. Keratitis is an inflammatory disease of the...

IDP-denovo: de novo transcriptome assembly and isoform annotation by hybrid sequencing.

In the past years, the long read (LR) sequencing technologies, such as Pacific Biosciences and Oxford Nanopore Technologies, have been demonstrated to substantially improve the quality of genome assem...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Field study on loose farrowing in cold barns.

The aim of this field study was to examine the loose farrowing system in view of practicability, particularly to monitor piglet losses and their causes, on a farm proceeding in accordance with the BIO...

Clinical Trials [56 Associated Clinical Trials listed on BioPortfolio]

Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging

Background: Painful vasoocclusive crisis (VOC) occurs in people with sickle cell disease (SCD). People with VOC have many visits to the hospital. About 10 30 percent of these people will ...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Post Market Study of DeNovo NT, Natural Tissue Graft

The purpose of this post market study is to evaluate surgical implantation technique and the quality of repair of the cartilage defect with particulated juvenile cartilage in the human kne...

Companies [536 Associated Companies listed on BioPortfolio]

Denovo Biolabels GmbH

Denovo Biolabels GmbHspecializes in the development of fluorescent markers for bioanalytical application

Denovo Biolabels

Denovo Biolabels GmbHspecializes in the development of fluorescentmarkers for bioanalytical applications. The R&D team combinesa profound knowledge in theorganic synthesis of fluorescent dyes with ma...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

More Information about "Denovo Biolabels GmbH" on BioPortfolio

We have published hundreds of Denovo Biolabels GmbH news stories on BioPortfolio along with dozens of Denovo Biolabels GmbH Clinical Trials and PubMed Articles about Denovo Biolabels GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Denovo Biolabels GmbH Companies in our database. You can also find out about relevant Denovo Biolabels GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record